Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models

Pangenome-wide and molecular evolution analyses of the Pseudomonas aeruginosa species

(2016) Jeanneth Mosquera-Rendón et al.   BMC GENOMICS

Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: Protective efficacy in a murine burn wound sepsis model

(2016) Bahador Behrouz et al.   BURNS

Biochemical and functional characterization of the periplasmic domain of the outer membrane protein A from enterohemorrhagic Escherichia coli

(2016) Haiguang Wang et al.   MICROBIOLOGICAL RESEARCH

A Novel Anti-PcrV Antibody Providing Enhanced Protection against Pseudomonas aeruginosa in Multiple Animal Infection Models

(2014) Paul Warrener et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Specific Humoral Immune Response Induced by Propionibacterium acnes Can Prevent Actinobacillus pleuropneumoniae Infection in Mice

(2014) Feng Yang et al.   Clinical and Vaccine Immunology

Vaccine development and passive immunization for Pseudomonas aeruginosa in critically ill patients: a clinical update

(2014) Jean-Louis Vincent   Future Microbiology

Phase separation of myelin sheath in Triton X-114 solution: predominant localization of the 21.5-kDa isoform of myelin basic protein in the lipid raft-associated domain

(2014) M. Uruse et al.   JOURNAL OF BIOCHEMISTRY

IL-17 Is a Critical Component of Vaccine-Induced Protection against Lung Infection by Lipopolysaccharide-Heterologous Strains of Pseudomonas aeruginosa

(2014) G. P. Priebe et al.   JOURNAL OF IMMUNOLOGY

AhR sensing of bacterial pigments regulates antibacterial defence

(2014) Pedro Moura-Alves et al.   NATURE

T Helper Cell Subsets Specific for Pseudomonas aeruginosa in Healthy Individuals and Patients with Cystic Fibrosis

(2014) Hannah K. Bayes et al.   PLoS One

PcrV antibody protects multi-drug resistant Pseudomonas aeruginosa induced acute lung injury

(2014) Qin Wang et al.   RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY

Vaccination against respiratoryPseudomonas aeruginosainfection

(2014) Keith Grimwood et al.   Human Vaccines & Immunotherapeutics

Prevalence, Risk Factors, and Mortality for Ventilator-Associated Pneumonia in Middle-Aged, Old, and Very Old Critically Ill Patients*

(2013) Stijn Blot et al.   CRITICAL CARE MEDICINE

Haemolysin Coregulated Protein Is an Exported Receptor and Chaperone of Type VI Secretion Substrates

(2013) Julie M. Silverman et al.   MOLECULAR CELL

Anti-PcrV antibody in cystic fibrosis: A novel approach targetingPseudomonas aeruginosaairway infection

(2013) Carlos E. Milla et al.   PEDIATRIC PULMONOLOGY

Evaluation of the Protective Immunity of a Novel Subunit Fusion Vaccine in a Murine Model of Systemic MRSA Infection

(2013) Qian-Fei Zuo et al.   PLoS One

A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of aPseudomonas aeruginosahybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers

(2013) Kerstin Westritschnig et al.   Human Vaccines & Immunotherapeutics

Pseudomonas aeruginosa: new insights into pathogenesis and host defenses

(2013) Shaan L. Gellatly et al.   Pathogens and Disease

Th17-stimulating Protein Vaccines Confer Protection againstPseudomonas aeruginosaPneumonia

(2012) Weihui Wu et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Development of a Fourfold Multiplexed Opsonophagocytosis Assay for Pneumococcal Antibodies against Additional Serotypes and Discovery of Serological Subtypes in Streptococcus pneumoniae Serotype 20

(2012) Robert L. Burton et al.   Clinical and Vaccine Immunology

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa

(2012) Bruno François et al.   CRITICAL CARE MEDICINE

Pneumonia Due to Pseudomonas aeruginosa

(2011) Hsin-Yun Sun et al.   CHEST

PcrV antibody–antibiotic combination improves survival in Pseudomonas aeruginosa-infected mice

(2011) Y. Song et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal Immunity

(2011) Kong Chen et al.   IMMUNITY

Pharmacokinetics and safety of panobacumab: specific adjunctive immunotherapy in critical patients with nosocomial Pseudomonas aeruginosa O11 pneumonia

(2011) Q. Lu et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Animal models of external traumatic wound infections

(2011) Tianhong Dai et al.   Virulence

Fusion expression and immunogenicity of Bordetella pertussis PTS1-FHA protein: implications for the vaccine development

(2010) Zhang Jinyong et al.   MOLECULAR BIOLOGY REPORTS

Candida albicans impairs macrophage function and facilitates Pseudomonas aeruginosa pneumonia in rat*

(2009) Damien Roux et al.   CRITICAL CARE MEDICINE

A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa

(2009) E. T. Weimer et al.   INFECTION AND IMMUNITY

Inescapable Need for Neutrophils as Mediators of Cellular Innate Immunity to Acute Pseudomonas aeruginosa Pneumonia

(2009) A. Y. Koh et al.   INFECTION AND IMMUNITY

Determination of protein oligomerization state: Two approaches based on glutaraldehyde crosslinking

(2007) Vasiliki E. Fadouloglou et al.   ANALYTICAL BIOCHEMISTRY